NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/12/2023
Back to search
Official data from USPTO
7 KEY PRINCIPLES OF CANCER THERAPY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
7 KEY PRINCIPLES OF CANCER THERAPY
ST13
US500000097291022Class
44
Filing
97291022
Registration
7160576
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
23
Latest update
09/12/2023
Trademark type
Word
Nice classes
44
Filing date
03/02/2022
Registration date
09/12/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/12/2023
Last transaction
09/12/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
04/30/2019
First use in commerce
04/30/2019
Drawing code
4
Owner type
01
Owner location
El Cajon, CA, US
Examiner
SOUDERS, MICHAEL J
Law office
M60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Jimenez, Antonio
Representatives
Yvonne Graf
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Medical treatment of cancer consisting of seven components
Publications
History of USPTO decisions and trademark events.
23 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
09/12/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/27/2023
PUBO
PUBLISHED FOR OPPOSITION
06/27/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/07/2023
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
05/25/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/18/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/17/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/16/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/16/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/03/2023
GNRT
NON-FINAL ACTION E-MAILED
04/03/2023
CNRT
NON-FINAL ACTION WRITTEN
04/03/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/03/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/03/2023
ALIE
ASSIGNED TO LIE
04/01/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/12/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/19/2022
GNRT
NON-FINAL ACTION E-MAILED
12/19/2022
CNRT
NON-FINAL ACTION WRITTEN
12/19/2022
DOCK
ASSIGNED TO EXAMINER
12/13/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/07/2022
NWAP
NEW APPLICATION ENTERED
03/05/2022
Continuous trademark protection
Get notified about every new filing that threatens 7 KEY PRINCIPLES OF CANCER THERAPY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.